Lv1
30 积分 2023-09-05 加入
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1天前
待确认
The present and future of bispecific antibodies for cancer therapy
1天前
已完结
The global burden of lung cancer: current status and future trends
2天前
已完结
Clinical implications of T cell exhaustion for cancer immunotherapy
3个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5个月前
已完结
Induction of immortal-like and functional CAR T cells by defined factors
8个月前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol
10个月前
已完结
A guide to cell death pathways
10个月前
已完结
Oncolytic viruses as engineering platforms for com- bination immunotherapy
10个月前
已完结
Therapy with oncolytic viruses: progress and challenges
10个月前
已完结
皖公网安备34019202002308
